Investing.com - Atossa Genetics (NASDAQ: ATOS) reported second quarter EPS of $-0.0800, $0.02 worse than the analyst estimate of $-0.0600. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.
Atossa Genetics's stock price closed at $1.0500. It is up 47.2900% in the last 3 months and down -12.2800% in the last 12 months.
Atossa Genetics saw positive EPS revisions and negative EPS revisions in the last 90 days. See Atossa Genetics's stock price’s past reactions to earnings here.
According to InvestingPro, Atossa Genetics's Financial Health score is "good performance".
Check out Atossa Genetics's recent earnings performance, and Atossa Genetics's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar